These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 21469973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL.
    Menopause; 2005 May 20; 12(6):716-27. PubMed ID: 16278615
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
    White WB, Pitt B, Preston RA, Hanes V.
    Circulation; 2005 Sep 27; 112(13):1979-84. PubMed ID: 16186434
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drospirenone and estradiol: a new option for the postmenopausal woman.
    Archer DF.
    Climacteric; 2007 Feb 27; 10 Suppl 1():3-10. PubMed ID: 17364592
    [Abstract] [Full Text] [Related]

  • 11. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H.
    Climacteric; 2011 Oct 27; 14(5):581-9. PubMed ID: 21848497
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 27; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 14. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
    Palacios S, Foidart JM, Genazzani AR.
    Maturitas; 2006 Nov 20; 55(4):297-307. PubMed ID: 16949774
    [Abstract] [Full Text] [Related]

  • 15. Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.
    Junge W, El-Samalouti V, Gerlinger C, Schaefers M.
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec 20; 147(2):195-200. PubMed ID: 19879683
    [Abstract] [Full Text] [Related]

  • 16. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H, Taketani Y.
    Climacteric; 2009 Aug 20; 12(4):319-28. PubMed ID: 19330598
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA, Skouby S, Rees M, Heikkinen J, Kudela M, Stadnicki-Kolendo A, Mattila L, Salminen K, Vuorela A, Mustonen M, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):124-31. PubMed ID: 17785038
    [Abstract] [Full Text] [Related]

  • 18. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.